• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532649
INE023H01027
36.7483544
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECLIFE
0
229.03
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales0.005.876.15
Other Operating Income0.000.710.01
Other Income 88.810.030.32
Total Income88.815.745.56
Total Expenditure 55.28181.7268.63
PBIDT33.53-175.98-63.07
Interest 30.220.000.00
PBDT3.31-175.98-63.07
Depreciation0.060.200.53
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-11.02-0.18-0.37
Reported Profit After Tax14.27-176.01-63.23
Extra-ordinary Items 34.80-175.68-62.55
Adjusted Profit After Extra-ordinary item-20.53-0.33-0.68
EPS (Unit Curr.)0.64-7.84-2.82
EPS (Adj) (Unit Curr.)0.64-7.84-2.82
Calculated EPS (Unit Curr.)0.64-7.85-2.82
Calculated EPS (Adj) (Unit Curr.)0.64-7.85-2.82
Calculated EPS (Ann.) (Unit Curr.)2.55-31.39-11.28
Calculated EPS (Adj) (Ann.) (Unit Curr.)2.55-31.39-11.28
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity22.4322.4322.43
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)0.00-3519.60-1205.93
PBDTM(%)0.00-3519.60-1205.93
PATM(%)0.00-3520.20-1208.99